Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients

International Journal of Colorectal Disease

Volumn 22, Issue 3, 2007, Pages 293-301

  Heuschen, Gundi ^c   Leowardi, Christine ^a   Hinz, Ulf ^a   Autschbach, Frank ^a   Stallmach, Andreas ^b   Herfarth, Christian ^a   Heuschen, Udo A ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Klinik für Anästhesiologie und Operative Intensivmedizin   (Germany)

^c St Vincenz Krankenhaus   (Germany)

Author keywords

Pouchitis; Toll like receptor; Ulcerative colitis

Indexed keywords

MESSENGER RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5;

ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; ILEITIS; INTESTINE ENDOSCOPY; INTESTINE MUCOSA; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SYMPTOM; ULCERATIVE COLITIS;

ADULT; BACTERIAL INFECTIONS; COLITIS, ULCERATIVE; COLONIC POUCHES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTESTINAL MUCOSA; MALE; POUCHITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5;

EID: 33846045278     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0133-6     Document Type: Article

References (51)

1. Sandborn WJ (1994) Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis and treatment. Gastroenterology 107:1856-1860
2. Nicholls RJ, Banerjee AK (1998) Pouchitis: Risk factors, etiology and treatment. World J Surg 22:347-351
3. Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH (1998) J ileal pouch-anal anastomosis for chronic ulcerative colitis: Complications and long-term outcome in 1310 patients. Br J Surg 85:800-803
4. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF (1994) Pouchitis after ileal pouch-anal anastomosis: A pouchitis disease activity index. Mayo Clin Proc 69:409-415
5. Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Bevins CL, Brezinski A, Petras RE, Fazio VW (2001) Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 121:261-267
6. Heuschen UA, Autschbach F, Allemeyer EH, Zöllinger AM, Heuschen G, Uehlein T, Herfarth C, Stern J (2001) Long-term follow-up after ileoanal pouch procedure. Dis Colon Rectum 44:487-499
7. Heuschen UA, Allemeyer EH, Hinz U, Autschbach F, Uehlein T, Herfarth C, Heuschen G (2002) Diagnosing pouchitis. Dis Colon Rectum 45:776-788
8. Rauh SM, Schoetz DJ, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC (1991) Pouchitis-s it a wastebasket diagnosis? Dis Colon Rectum 34:685-689
9. Luukkonen P, Ja7die;rvinen H, Tanskanen M Kahri M (1994) Pouchitis - recurrence of inflammatory bowel disease? Gut 35:243-246
10. Nygaard K, Bergan T, Bj0rneklett A, Hoverstad T, Lassen J, Aase S (1994) Topical metronidazole treatment in pouchitis. Scand J Gastroenterol 29:462-467
11. Campierei M, Gionchetti P (1999) Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 116:1246-1260
12. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119:305-309
13. Madden MV, McIntyre AS, Nicholls RJ (1994) Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 39:1193-1196
14. Madsen K, Cornish A, Soper P, McKaigney C, Humberto J, Yachimec C, Doyle J, Jewell L, de Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591
15. Sartor RB (2000) Probiotics in chronic pouchitis: Restoring luminal microbial balance. Gastroenterology 119:584-587
16. Ruseler-van Embden JG, Schouten WR, van Lieshout LM (1994) Pouchitis: result of microbial imbalance? Gut 35:658-664
17. Fiocchi C (1998) Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 115:182-205
18. Sartor RB (1995) Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB, Shorter RG (eds) Inflammatory bowel disease, 4th edn. Williams & Wilkins, Baltimore, MD, pp 96-124
19. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell-lines expressing Toll-like receptors. J Immunol 164:966-972
20. Modlin RL (2002) Mammalian Toll-like-receptors. Ann Allergy Asthma Immunol 88:543-554
21. Underhill DM, Ozinsly A (2002) Toll-like-receptors: Key mediators of microbe detection. Curr Opin Immunol 14:103-110
22. Qureshi ST, Gros P, Malo D (1999) Host resistance to infection: Genetic control of lipopolysaccharide responsiveness by TOLL-like receptors genes. Trends Genet 15:291-294
23. Kopp EB, Medzhitov R (1999) The Toll-receptor family and control of innate immunity. Curr Opin Immunol 11:13-18
24. Anderson KV (2000) Toll signaling pathways in the innate immune response. Curr Opin Immunol 12:13-19
25. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT (1999) Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274:33419-33425
26. Yang RB, Mark MR, Gurney AL, Godowsky PJ (1999) Signaling events by lipopolysaccharide-activated toll-like-receptor 2. J Immunol 163:639-643
27. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell-wall components. Immunity 11:443-451
28. Beutler B (2000) TLR4: Central component of the sole mammalian LPS sensor. Curr Opin Immunol 12:20-26
29. Alexopoulou L, Czopik Holt A, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NFκB by Toll-like receptor 3. Nature 413:732-738
30. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL (2001) Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167:1882-1885
31. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like-receptor 5. Nature 410:1099-1103
32. Mizel SB, Snipes JA (2002) Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor-associated kinase release from Toll-like receptor 5. J Biol Chem 277:22414-22420
33. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like-receptors. Science 285:732-736
34. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A (1999) Cell activation and apoptosis by bacterial lipoproteins through Toll-like-receptor-2. Science 285:736-739
35. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Bolcskei PL, Wagner M, Akira S, Norgard MV, Belisle JT, Godowski PJ, Bloom BR, Modlin RL (2001) Induction of direct antimicrobial activity through mammalian toll-like-receptors. Science 291:1544-1547
36. Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A (2000) The apoptotic signaling pathway activated by Toll-like-receptor 2. EMBO J 19:3325-3336
37. Abreu M, Vora P, Faure E, Thomas L, Arnold E, Arditi M (2001) Decreased expression of TLR4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167:1609-1616
38. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF, Kubagawa H (2001) Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167:2651-2656
39. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H (2001) Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167:2250-2256
40. Naik S, Kelly EJ, Meijer L, Petterson S, Sanderson IR (2001) Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr 32:449-453
41. Cario E, Podolsky DK (2000) Differential alteration in intestinal epithelial cell expression of TLR3 and TLR4 in inflammatory bowel disease. Infect Immun 68:7010-7017
42. Hausmann M, Kiessling S, Mestermann S, Webb G, Spöttl T, Andus T, Schölmerich J, Herfarth H, Ray K, Falk W, Rogler G (2002) Toll-like-receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122:1987-2000
43. Pasquali D, Bellastella A, Valente A, Botti G, Capasso I, del Vecchio S, Salvatore M, Colantuoni V, Sinisi AA (1997) Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer. Eur J Endocrinol 137:410-414
44. Dieterich KD, Lehnert H (2000) Decreased expression of corticotropin-releasing factor-binding protein mRNA in ACTH-secreting pituitary adenomas. Exp Clin Endocrinol Diabetes 108:59-62
45. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998) Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: Mutations in Tlr4 gene. Science 282:2085-2088
46. Lorenz E, Mira JP, Frees KL, Schwartz DA (2002) Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028-1032
47. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviäre J, Rutgeerts P (2004) Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299Gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53:987-992
48. Muzio M, Polentarutti N, Bosisio D, Prahladan MKP, Mantovani A (2000) Toll-like receptors: A growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 67:450-456
49. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RN (2004) Bacterial flagellin is a dominant antigen in Crohn's disease. J Clin Invest 113:1296-1306
50. Gitter AH, Wullstein F, Fromm M, Sculzke JD (2001) Epithelial barrier defects in ulcerative colitis: Characterization and quantification by electrophysiological imaging. Gastroenterology 121:1320-1328
51. Andreakos E, Foxwell B, Feldmann M (2004) Is targeting TOLL-like receptors and their signalling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol Rev 202:250-265